Industry Symposium by Bracco

IND 11 - Redefining excellence in contrast-enhanced MRI: the benefits of gadopiclenol (Vueway)

February 27, 12:30 - 13:30 CET

10 min
Introduction
Francesco Sardanelli, Milan / Italy
15 min
Safety and sustainability: evaluating the impact of reduced dose gadopiclenol
Alberto Spinazzi, Monroe Township / United States
To provide up-to-date information on the clinical safety of gadopiclenol ; To describe how a reduced dose of gadolinium is a more sustainable solution for contrast-enhanced MRI
15 min
Gadopiclenol: the advantages of high relaxivity for MR imaging of the CNS
Simonetta Gerevini, Cremona / Italy
To demonstrate how higher r1 relaxivity permits GBCA dose lowering for CNS applications without loss of diagnostic information
15 min
Oncologic imaging: a case view of gadopiclenol across approved indications
Guenther Schneider, Homburg/Saar / Germany
To demonstrate the benefits of 0.05 mmol/kg gadopiclenol for MRI of abdominal organs